Effect of illegal substance use on cognitive function in individuals with a psychotic disorder, a review and meta-analysis

Neuropsychology

Volumn 26, Issue 6, 2012, Pages 785-801

  Donoghue, Kim ^a   Doody, Gillian A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cognitive function; Meta analysis; Psychosis; Substance abuse

Indexed keywords

CANNABIS; COCAINE; ILLICIT DRUG;

COGNITION; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFECT; EXECUTIVE FUNCTION; FRONTAL LOBE; HUMAN; META ANALYSIS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOMOTOR ACTIVITY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; VERBAL MEMORY; WORKING MEMORY;

COGNITION DISORDERS; COMORBIDITY; HUMANS; MEMORY DISORDERS; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 84874422686     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/a0029685     Document Type: Review

References (73)

1. Addington, J., & Addington, D. (1997). Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatry & Neuroscience, 22, 99-104.
2. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
3. Barch, D. M., & Carter, C. S. (2005). Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. Schizophrenia Research, 77, 43-58. doi:10.1016/j.schres.2004.12.019
4. Barnes, T. R. E., Mutsatsa, S. H., Hutton, S. B., Watt, H. C., & Joyce, E. M. (2006). Comorbid substance use and age at onset of schizophrenia. The British Journal of Psychiatry, 188, 237-242. doi:10.1192/bjp.bp.104.007237
5. Barnett, J. H., Werners, U., Secher, S. M., Hill, K. E., Brazil, R., Masson, K.,... Jones, P. B. (2007). Substance use in a population-based clinical sample of people with first-episode psychosis. The British Journal of Psychiatry, 190, 515-520. doi:10.1192/bjp.bp.106.024448
6. Bax, L., Yu, L., Ikeda, N., Tsuruta, H., & Moons, K. G. M. (2006). Development and validation of MIX: Comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology, 6, 50. doi:10.1186/1471-2288-6-50
7. Bersani, G., Orlandi, V., Kotzalidis, G. D., & Pancheri, P. (2002). Cannabis and schizophrenia: Impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience, 252, 86-92. doi:10.1007/s00406-002-0366-5
8. Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59, 1337-1343. doi:10.1212/01.WNL.0000031422.66442.49
9. Cantor-Graae, E., Nordström, L., & McNeil, T. F. (2001). Substance abuse in schizophrenia: A review of the literature and a study of correlates in Sweden. Schizophrenia Research, 48, 69 - 82. doi:10.1016/S0920-9964(00)00114-6
10. Cantwell, R., Brewin, J., Glazebrook, C., Dalkin, T., Fox, R., Medley, I., & Harrison, G. (1999). Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry, 174, 150-153. doi: 10.1192/bjp.174.2.150
11. Carey, K. B., Carey, M. P., & Simons, J. S. (2003). Correlates of substance use disorder among psychiatric outpatients: Focus on cognition, social role functioning, and psychiatric status. Journal of Nervous and Mental Disease, 191, 300-308. doi:10.1097/01.NMD.0000066152.87832.A9
12. Cleghorn, J. M., Kaplan, R. D., Szechtman, B., Szechtman, H., Brown, G. M., & Franco, S. (1991). Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry, 52, 26-30.
13. Cohen, M., Solowij, N., & Carr, V. (2008). Cannabis, cannabinoids, and schizophrenia: Integration of the evidence. Australian and New Zealand Journal of Psychiatry, 42, 357-368. doi:10.1080/00048670801961156
14. Cooper, L., Liberman, D., Tucker, D., Nuechterlein, K. H., Tsuang, J., & Barnett, H. L. (1999). Neurocognitive deficits in the dually diagnosed with schizophrenia and cocaine abuse. Psychiatric Rehabilitation Skills, 3, 231-245. doi:10.1080/10973439908408386
15. Copersino, M. L., Serper, M. R., Vadhan, N., Goldberg, B. R., Richarme, D., Chou, J. C. Y.,... Cancro, R. (2004). Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Research, 128, 209-218. doi:10.1016/j.psychres.2004.07.006
16. Coulston, C. M., Perdices, M., Henderson, A. F., & Malhi, G. S. (2010). Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use. Schizophrenia Research and Treatment [online]. Retrieved from http://downloads.hindawi.com/journals/sprt/2011/501726.pdf
17. Coulston, C. M., Perdices, M., & Tennant, C. C. (2007). The neuropsychology of cannabis and other substance use in schizophrenia: Review of the literature and critical evaluation of methodological issues. Australian and New Zealand Journal of Psychiatry, 41, 869-884. doi:10.1080/00048670701634952
18. DeRosse, P., Kaplan, A., Burdick, K. E., Lencz, T., & Malhotra, A. K. (2010). Cannabis use disorders in schizophrenia: Effects on cognition and symptoms. Schizophrenia Research, 120, 95-100. doi:10.1016/j.schres.2010.04.007
19. Di Sclafani, V., Tolou-Shams, M., Price, L. J., & Fein, G. (2002). Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug and Alcohol Dependence, 66, 161-171. doi:10.1016/S0376-8716(01)00197-1
20. Dixon, L., Haas, G., Weiden, P. J., Sweeney, J., & Frances, A. J. (1991). Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. The American Journal of Psychiatry, 148, 224-230.
21. Fox, H. C., Toplis, A. S., Turner, J. J. D., & Parrott, A. C. (2001). Auditory verbal learning in drug-free ecstasy polydrug users. Human Psychopharmacology: Clinical and Experimental, 16, 613-618. doi:10.1002/hup.344
22. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? The American Journal of Psychiatry, 153, 321-330.
23. Harrison, I., Joyce, E. M., Mutsatsa, S. H., Hutton, S. B., Huddy, V., Kapasi, M., & Barnes, T. R. E. (2008). Naturalistic follow-up of comorbid substance use in schizophrenia: The West London first-episode study. Psychological Medicine, 38, 79 - 88. doi:10.1017/S0033291707000797
24. Harvey, P. D., & Keefe, R. S. E. (2001). Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. The American Journal of Psychiatry, 158, 176 -184. doi:10.1176/appi.ajp.158.2.176
25. Heinrichs, R. W., & Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12, 426-445. doi:10.1037/0894-4105.12.3.426
26. Herman, M. (2004). Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. International Journal of Mental Health Nursing, 13, 282-291. doi: 10.1111/j.1440-0979.2004.00346.x
27. Hyde, T. M., & Lewis, S. W. (2003). The secondary schizophrenias. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (2nd ed., pp. 185-202). Oxford, England: Blackwell Publishing Company. doi: 10.1002/9780470987353.ch11
28. Indlekofer, F., Piechatzek, M., Daamen, M., Glasmacher, C., Lieb, R., Pfister, H.,... Schütz, C. G. (2009). Reduced memory and attention performance in a population-based sample of young adults with moderate lifetime use of cannabis, ecstasy and alcohol. Journal of Psychopharmacology, 23, 495-509. doi:10.1177/0269881108091076
29. Jockers-Scherübl, M. C., Wolf, T., Radzei, N., Schlattmann, P., Rentzsch, J., Gómez-Carrillo de Castro, A., & Kühl, K. P. (2007). Cannabis induces different cognitive changes in schizophrenic patients and healthy controls. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1054-1063. doi:10.1016/j.pnpbp.2007.03.006
30. Kedzior, K. K., Badcock, J., & Martin-Iverson, M. (2006). Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Substance Use and Misuse, 41, 743-750. doi:10.1080/10826080500411502
31. Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999). The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophrenia Bulletin, 25, 201-222. doi:10.1093/oxfordjournals.schbul.a033374
32. Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011). Cannabis use and earlier age of onset of psychosis: A systematic metaanalysis. Archives of General Psychiatry, 68, 555-561. doi:10.1001/archgenpsychiatry.2011.5.
33. Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). New York, NY: Oxford University Press
34. Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279. doi:10.1001/archpsyc.1994.03950040017002
35. Lundqvist, T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81, 319-330. doi:10.1016/j.pbb.2005.02.017
36. Malaspina, D., Goetz, R. R., Friedman, J. H., Kaufmann, C. A., Faraone, S. V., Tsuang, M.,... Blehar, M. C. (2001). Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees. The American Journal of Psychiatry, 158, 440-446. doi:10.1176/appi.ajp.158.3.440
37. McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J.,... Ricaurte, G. A. (2008). Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse, 62, 91-100. doi:10.1002/syn.20471
38. McCleery, A., Addington, J., & Addington, D. (2006). Substance misuse and cognitive functioning in early psychosis: A 2-year follow-up. Schizophrenia Research, 88, 187-198. doi:10.1016/j.schres.2006.06.040
39. Morgan, V. A., Leonard, H., Bourke, J., & Jablensky, A. (2008). Intellectual disability co-occurring with schizophrenia and other psychiatric illness: Population-based study. The British Journal of Psychiatry, 193, 364-372. doi:10.1192/bjp.bp.107.044461
40. O'Leary, D. S., Flaum, M., Kesler, M. L., Flashman, L. A., Arndt, S., & Andreasen, N. C. (2000). Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences, 12, 4-15.
41. O'Malley, S., Adamse, M., Heaton, R. K., & Gawin, F. H. (1992). Neuropsychological impairment in chronic cocaine abusers. The American Journal of Drug and Alcohol Abuse, 18, 131-144. doi:10.3109/00952999208992826
42. Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47, 853-858.
43. Pencer, A., & Addington, J. (2003). Substance use and cognition in early psychosis. Journal of Psychiatry & Neuroscience, 28, 48-54.
44. Pietrzak, R. H., Snyder, P. J., & Maruff, P. (2010). Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. Human Psychopharmacology: Clinical and Experimental, 25, 353-358. doi:10.1002/hup.1118
45. Potvin, S., Briand, C., Prouteau, A., Bouchard, R., Lipp, O., Lalonde, P.,... Stip, E. (2005). CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition, 59, 38-42. doi: 10.1016/j.bandc.2005.04.002
46. Potvin, S., Joyal, C. C., Pellitier, J., & Stip, E. (2008). Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophrenia Research, 100, 242-251. doi: 10.1016/j.schres.2007.04.022
47. Potvin, S., Pampoulova, T., Lipp, O., Aït Bentaleb, L., Lalonde, P., & Stip, E. (2008). Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cognitive Neuropsychiatry, 13, 357-366. doi:10.1080/13546800802264330
48. Rodriguez-Jimenez, R., Aragües, M., Jimenez-Arriero, M. A., Ponce, G., Martinez, I., Hoenicka, J.,... Psychosis and Addictions Research Group (PARG). (2008). Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: Influence of dual diagnosis. Psychopathology, 41, 58-64. doi:10.1159/000110627
49. Rund, B. R. (1998). A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin, 24, 425-435. doi: 10.1093/oxfordjournals.schbul.a033337
50. Scallet, A. C. (1991). Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals. Pharmacology Biochemistry and Behavior, 40, 671-676. doi:10.1016/0091-3057(91)90380-K
51. Schilt, T., de Win, M. M. L., Jager, G., Koeter, M. W., Ramsey, N. F., Schmand, B., & van den Brink, W. (2008). Specific effects of ecstasy and other illicit drug on cognition in poly-substance users. Psychological Medicine, 38, 1309-1317. doi:10.1017/S0033291707002140
52. Schnell, T., Koethe, D., Daumann, J., & Gouzoulis-Mayfrank, E. (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology, 205, 45-52. doi:10.1007/s00213-009-1512-9
53. Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, H., & Grant, I. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review, 17, 275-297. doi:10.1007/s11065-007-9031-0
54. Serper, M. R., Bergman, A., Copersino, M. L., Chou, J. C. Y., Richarme, D., & Cancro, R. (2000). Learning and memory impairment in cocainedependent and comorbid schizophrenic patients. Psychiatry Research, 93, 21-32. doi:10.1016/S0165-1781(99)00122-5
55. Serper, M. R., Copersino, M. L., Richarme, D., Vadhan, N., & Cancro, R. (2000). Neurocognitive functioning in recently abstinent, cocaineabusing schizophrenic patients. Journal of Substance Abuse, 11, 205-213. doi:10.1016/S0899-3289(00)00021-3
56. Sevy, S., Burdick, K. E., Visweswaraiah, H., Abdelmessih, S., Lukin, M., Yechiam, E., & Bechara, A. (2007). Iowa Gambling Task in schizophrenia: A review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophrenia Research, 92, 74-84. doi:10.1016/j.schres.2007.01.005
57. Sevy, S., Kay, S. R., Opler, L. A., & van Praag, H. M. (1990). Significance of cocaine history in schizophrenia. Journal of Nervous and Mental Disease, 178, 642-648. doi:10.1097/00005053-199010000-00005
58. Sevy, S., Robinson, D. G., Holloway, S., Alvir, J. M., Woerner, M. G., Bilder, R.,... Kane, J. (2001). Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 104, 367-374. doi:10.1034/j.1600-0447.2001.00452.x
59. Silber, B. Y., Croft, R. J., Papafotiou, K., & Stough, C. (2006). The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology, 187, 154-169. doi: 10.1007/s00213-006-0410-7
60. Smelson, D. A., Davis, C. W., Di Pano, R., Johnson, V., Losonczy, M. F., & Ziedonis, D. (2002). Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. Journal of Nervous and Mental Disease, 190, 200-202. doi: 10.1097/00005053-200203000-00010
61. Smelson, D. A., Davis, C. W., Eisenstein, N., Engelhart, C., Williams, J., Losonczy, M. F., & Ziedonis, D. (2003). Cognitive disparity in schizophrenics with and without cocaine dependency. Journal of Substance Abuse Treatment, 24, 75-79. doi:10.1016/S0740-5472(02)00324-0
62. Stirling, J., Lewis, S., Hopkins, R., & White, C. (2005). Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year followup. Schizophrenia Research, 75, 135-137. doi:10.1016/j.schres.2004.10.006
63. Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms and commentary (3rd ed.). New York, NY: Oxford University Press.
64. The Cochrane Collaboration. (2008). RevMan Version 5.0.23. Retrieved from http://www.cc-ims.net/RevMan
65. Thoma, P., & Daum, I. (2008). Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. Addiction, 103, 774-786. doi:10.1111/j.1360-0443.2008.02156.x
66. Thoma, P., Wiebel, B., & Daum, I. (2007). Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder. Schizophrenia Research, 92, 168-180. doi:10.1016/j.schres.2007.02.004
67. Tuulio-Henriksson, A., Partonen, T., Suvisaari, J., Haukka, J., & Lönnqvist, J. (2004). Age at onset and cognitive functioning in schizophrenia. The British Journal of Psychiatry, 185, 215-219. doi:10.1192/bjp.185.3.215
68. Verdejo-García, A. J., López-Torrecillas, F., Aguilar de Arcos, F., & Pérez-García, M. (2005). Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis. Addictive Behaviors, 30, 89-101. doi:10.1016/j.addbeh.2004.04.015
69. Verdejo-García, A., & Pérez-García, M. (2007). Profile of executive deficits in cocaine and heroin polysubstance users: Common and differential effects on separate executive components. Psychopharmacology, 190, 517-530. doi:10.1007/s00213-006-0632-8
70. Wobrock, T., Sittinger, H., Behrendt, B., D'Amelio, R., Falkai, P., & Caspari, D. (2007). Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 257, 203-210. doi:10.1007/s00406-006-0707-x
71. World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: Author.
72. Yücel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M.,... Pantelis, C. (2010). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin, 38, 316-330. doi:10.1093/schbul/sbq079
73. Zanelli, J., Reichenberg, A., Morgan, K., Fearon, P., Kravariti, E., Dazzan, P.,... Murray, R. M. (2010). Specific and generalized neuropsychological deficits: A comparison of patients with various first-episode psychosis presentations. The American Journal of Psychiatry, 167, 78-85. doi:10.1176/appi.ajp.2009.09010118